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ABSTRACT 
 
In the present clinical study, the effect of oligofructose-enriched inulin was studied on bone metabolism in girls from 
9 to 12 years old, with low habitual calcium intakes, who attended public schools. Two calcium-enriched 
formulations, supplemented with oligofructose-enriched inulin (test drink) or without (standard drink) were made. 
Sixty pre-pubertal girls were randomized into a double-blind and crossover design, divided into three groups and 
received one daily portion of either the standard drink (group 1) or test  drink (group 2) during 11 weeks, followed 
by a three-week washout period. Group control did not receive any supplementation. Biochemical evaluations of 
serum calcium, intact parathyroid hormone – iPTH – and bone alkaline phosphatase – BAP – were performed at 
baseline and after 4, 8 and 11 weeks of each intervention period. In group 1, a significant increase in serum calcium 
and BAP and a reduction of iPTH were observed after consumption of the test drink. 
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INTRODUCTION 
 
Calcium is the most abundant mineral in the body 
and is most present (approximately 99%) in bones 
and teeth. Only 1% is found in blood, extra 
cellular liquid and inside cells of soft tissue, where 
it regulates important metabolic functions (Ilich 
and Kerstetter, 2000). The peak of bone mass 
acquisition occurs until the third decade of life, 
and it is dependent on dietary calcium, which 
affects bone mineralization reserves and 
subsequent osteoporosis risk (Heaney, 2001a). It 
is, therefore, not surprising that calcium is the 
most studied nutrient with respect to bone health 
(Ilich and Kerstetter, 2000) and that high calcium 
intakes are considered as strategy in the prevention 
of osteoporosis. Nonetheless, food consumption 
patterns during adolescence clearly show that 
calcium intakes are often inadequate (Albano and 
Souza, 2001), especially in developing countries 
such as Brazil (Lerner et al., 2000; Johnson-Down 
et al., 2003). Therefore, strategies to improve the 
absorption of calcium from the diet are considered 
important. 
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Prebiotics are non-digestible food ingredients that 
selectively stimulate the growth and/or activity of 
a limited number of beneficial bacteria in the 
colon (mainly bifidobacteria and lactobacilli), 
thereby improving the host´s health. Inulin and 
oligofructose are prebiotic food ingredients that 
are naturally extracted from the chicory root 
(Chicorium intybus) (Roberfroid, 2007) and can 
also be found in plants originally from the 
Brazilian tropical savanna (cerrado), such as the 
families Vernoniae and Asteraceae (Hayashi and 
Appezzato-da-Glória, 2007). Intervention trials in 
adolescents with adequate calcium intakes have 
demonstrated a significant increase in calcium 
absorption and bone mineralization (bone mineral 
density and content) after supplementation with 
oligofructose-enriched inulin (8 g/d of Synergy1) 
(Griffin et al., 2002; Griffin et al., 2003; Abrams et 
al., 2005; Holloway et al., 2007). However, 
literature does not present data on populations with 
low calcium intakes.  
Bone development can be evaluated by bone 
biomarkers of formation and reabsorption. The use 
of these parameters has been increasing due to 
their low risk and reduced time of experiments. 
Formation markers measure products as a result of 
the osteoblast action, while reabsorption markers 
measure the osteoclast action, main cellular type 
involved on the reabsorption of bone matrix 
(Calvo et al., 1996; Vieira, 2000). Among 
formation markers, bone alkaline phosphatase 
(BAP) is commonly used and reflects the 
osteoblast activity and number related mainly to 
bone mineralization (Arnett and Henderson, 1998).  
Clinical assays evaluating biomarkers of bone 
metabolism have been carried with the male and 
female children and adolescents; however, this 
evaluation must be done carefully once their 
indexes are superior than the adult ones, due to 
children’s growth. These assays are advantageous 
in short-period interventions, differently from 
bone densitometry that requests an approximate 
time of 12 months (Vieira, 2007) and implicates in 
lower and higher cost. A way of avoiding an error 
in the interpretation of data is the evaluation of a 
control group, which allows the researcher to 
verify the growth in the studied period. 
The objective of the present clinical study was to 
evaluate the effect of oligofructose-enriched 
inulin, supplemented to a milk-based drink, on 
bone metabolism in girls aged 9 to 12 years, with 
low habitual calcium intakes. 
 
 
MATERIALS AND METHODS 
 
Subjects 
Sixty girls aged between 9.0 and 11.9 years old 
were selected among the healthy students of public 
schools in Umuarama (PR, Brazil). The volunteers 
were first interviewed by a dietitian, and calcium 
intakes were estimated using three 24-h food 
recalls (R24h). Only girls with habitual mean 
calcium intake of 500 mg/d and Tanner pubertal 
stage of 2 or 3 (breast) (Tanner, 1962) were 
considered eligible for the study. 
Girls were excluded from the study if they were 
postmenarcheal, received hormonal (including 
contraceptives) or corticosteroid therapy, vitamin 
or mineral supplementation, had kidney or 
gastrointestinal diseases, hyperparathyroidism, 
changes in bone metabolism or rheumatic diseases, 
tobacco addiction, pregnancy or breast feeding, or 
if they had BMI < 5o or > 95o percentile for sex 
and age (Bray, 1989). 
 
Dietary records 
Individuals eligible for the study were randomly 
divided into three groups with twenty participants 
in each group. The volunteers were evaluated in 
terms of food consumption and life style at 
baseline and at the end of the experiment. At the 
beginning of the study, 24-h food recalls (R24h) 
were taken for three days (including one weekend 
day), whereas at the end of the study, it included 
only one day. The American Food Composition 
Table (USDA, 2005) was used to estimate daily 
calcium intakes. Fructan intakes were estimated 
from published data (Van Loo et al., 1995; 
Paschoal, 2007). 
 
Milk-based drinks 
Two dry mixtures (standard and test) were used to 
prepare the non-fermented milks, both enriched 
with 200 mg calcium (per 200 ml of milk). The 
test drink was supplemented with 8 g 
oligofructose-enriched inulin (BeneoTM Synergy1, 
ORAFTI, Tienen, Belgium) (per 200 ml of milk). 
Drink formulations were prepared by Boa Safra 
Alimentos from Curitiba (PR, Brazil). General and 
sensory acceptances of the drinks were evaluated 
by a 7-point facial hedonic scale. This test is used 
to evaluate the preferences and/or acceptance of 
products for infants and children whose facial 
expressions easily tell their individual reactions to  
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a product. Each group of examiners was formed by 
fifty girls, aged between 9 and 12 years old, not 
trained, and selected randomly in four public 
schools in the city of Umuarama (PR, Brazil), and 
who had not taken part in the clinical assay. 
Analysis of the drinks were done for the moisture, 
ash, lipids (Instituto Adolfo Lutz, 1985) and 
protein (AOAC, 1995). Fructans were analyzed by 
HPLC-PAD (Hoebregs, 1997). Total and fecal 
coliforms, yeast and mould, total mesophiles and 
Salmonella scores were evaluated for the 
microbiological characterization of the samples 
(LANARA, 1981).  
 
Study design 
Sixty pre-pubertal girls with low habitual calcium 
intakes were randomly divided into three groups. 
Volunteers participating in the double-blind study 
were randomized into two groups (crossover 
design) with two 11-week intervention periods and 
a between-in washout of three weeks. Group 1 
received the standard milk-based drink during the 
first intervention and the test milk-based drink 
during the second intervention. Subjects in group 2 
received both interventions in reversed order. 
Subjects in group 3 (control group) did not receive 
any of the drinks and were asked to keep their 
habitual feeding and lifestyle. The implementation 
of a control group, receiving no supplementation, 
was considered necessary for the study once 
individuals at this age and maturation stage have 
various metabolic alterations and to which a 
comparison could be made. The presence of 
intestinal uncomforts such as diarrhea or 
flatulence, due to the prebiotic supplementation, 
was checked. 
Blood samples were taken at the Clinical Analysis 
Laboratory of the Universidade Paranaense from 
Umuarama (PR, Brazil) in the morning after an 
eight-hour fasting period. Blood was taken at 
baseline, and after 4, 8 and 11 weeks of each 
intervention period, totalizing eight samples per 
subject. These four evaluations aimed to test the 
sensibility of the biomarker used in shorter 
periods. All the analysis were performed in 
duplicate and included serum concentrations of 
calcium (Calcium Liquiform-Labtest Diagnostic 
kit); bone alkaline phosphatase (BAP) (Metra 
Biosystem Inc., Alkaphas-B kit, Mountain View, 
CA. USA); and intact parathyroid hormone (iPTH) 
(Roche Diagnostics). The intra and inter variation 
coefficients of the analysis were 0.78 and 1.07 for 
serum calcium, 5.8 and 7.6 for BAP and 2.0 and 
3.4 for iPTH, respectively. 
 
Statistical analysis 
The effect of treatment on bone metabolism 
between the groups and sampling times according 
to the weeks of study was assessed by ANOVA 
repeated measures test. In order to make the 
comparisons among times, the Profile test by 
contrasts was used. Tukey´s post-hoc test was used 
for between-group comparisons. For describing 
the profile of the sample, tables of frequency of 
categorical variables and descriptive statistics with 
position measures and dispersion of continuous 
variables were prepared. Pearson´s chi-square test 
was used to compare the categorical variables 
among the groups, or Fisher´s exact test was used 
when necessary. Kruskal-Wallis or Mann-Whitney 
test for variables without normal distribution were 
used to compare the numerical variables among 
the groups. In order to make the correlation 
analysis of the area under the curve (AUC) and 
area under the incremental curve (AUIC), 
Spearman´s correlation coefficient was used. 
Statistical analysis was carried out using The 
Statistical Analysis Systems software version 8.02 
(SAS Institute, Cary, NC, USA). Results were 
considered statistically significant when P<0.05.  
 
Ethical considerations 
The protocol (no 210) was submitted and approved 
by the Ethical Research Committee of the School 
of Pharmaceutical Science of the University of Sao 
Paulo (Brazil). Parents or legal guardians were 
informed of the study and a signed consent form 
was requested. 
 
 
RESULTS 
 
Product characterization and sensorial 
evaluation 
The standard and test milk-based drinks were 
similar in composition, except for the fructan 
content. The daily 200 ml portion of the test milky 
drink served to children during the intervention 
presented a concentration of 8 g of fructans and 
202.15 + 12.13 mg of calcium and the standard 
milky drink presented 205.28 + 15.08 mg of 
calcium. The ash contents of the test and the 
standard milky drinks, in the 200 ml portion, were 
2.03 and 2.50 g, lipids 4.82 and 4.12 g, protein  
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9.59 and 8.97 g, and carbohydrates 32.40 and 
32.50 g, respectively. Microbiological analysis 
confirmed the absence of any of the organisms 
studied. Sensorial analysis indicated no differences 
between standard and test milk-based drinks. 
 
Subject characteristics and biochemical 
parameters at baseline 
Fifty-three out of the sixty recruited volunteers 
completed the study. Discontinuation was due to 
move (four subjects), rejection of blood sampling 
(one subject), or dissatisfaction with the draft 
design (two subjects in the control group). The 
mean BMI of the subjects was 18 kg/m2. Mean 
calcium intakes were approximately 500 mg/d, and 
much lower than the AI for this age group (1300 
mg/d). There were no significant differences in 
BMI and calcium intakes among the studied 
groups (Kruskal-Wallis test).When the results of 
ANOVA for repeated measures were evaluated, in 
order to compare BMI and calcium intake among 
the groups and the sampling times according to the 
weeks of study, no significant statistical 
differences between the initial and final times 
occurred, neither on the interaction between the 
groups and sampling times. The similar intake of 
calcium between initial and final times showed the 
maintenance of food intake habits of the 
participants during the clinical assay. The mean 
daily intake of fructans among the volunteers was 
7.09 + 3.7 g. 
The subjects´ life style did not differ among the 
groups and remained the same during the course of 
the study; 81 to 94% of the subjects were white; 
65 to 90% of the subjects had regular physical 
activity (2-4 d/week). Approximately 80% of the 
girls had regular sun exposure (2 times/week, 
about 1 to 2 h/d). Stool frequency of the subjects 
remained constant along the study (except for one 
in group 2). Three girls (5%) of group 2 reported 
flatulence during the first 3 to 4 days of the 
intervention. None of the volunteers discontinued 
participation because of symptoms. Biochemical 
parameters in bone metabolism at baseline of the 
two intervention periods were not different among 
the participants (Table 1), which demonstrated a 
similarity of the participants of the three study 
groups, including the control group.  
 
Table 1 - Biochemical parameters evaluated at baseline of the two intervention periods of the clinical study. 
Group/Biochemichal 
parameter Group 1 (n=18) Group 2 (n=17) 
Control Group 
(n=18) Tukey test 
1st period 9.94 + 0.81 9.40 + 0.83 9.27 + 0.66 NS Calcium (mg/dl) 
2nd period 9.06 + 0.54 8.99 + 0.43 8.93 + 0.46 NS 
1st period 124.33 + 21.56 107.88 + 20.07 113.00 + 24.30 NS 
BAP (U/l) 2nd period 128.22 + 22.60 117.65 + 22.65 120.44 + 26.92 NS 
1st period 22.91 + 8.29 18.95 + 6.86 21.63 + 8.22 NS 
iPTH (pg/ml) 
2nd period 19.13 + 7.46 20.91 + 8.50 18.93 + 8.64 NS 
BAP, bone alkaline phoshatase; iPTH, intact parathyroid hormone; NS, not significant (P>0.05); Values are means + SD. 
 
 
Crossover study 
Figure 1 shows the mean concentrations of serum 
calcium at sampling times according to the weeks 
of study and per group. In group 1, calcium levels 
were significantly higher during the test drink 
intervention at the 18th and 22nd weeks of 
supplementation when compared to the standard 
drink (respectively P=0.005 and P<0.001). 
When the bone alkaline phosphatase (BAP) was 
compared at sampling times according to the 
weeks of study and per group (Fig. 1), there was a 
significant increase at the 18th week for both 
groups and at the 8th and 22nd weeks for group 1 
(P<0.001). Concentrations of intact parathyroid 
hormone at sampling times according to the weeks 
of study and per group are presented in Figure 1. 
There was a significant reduction at the 4th week 
only in group 1 and at the 18th and 22nd weeks in 
both groups (P<0.001). 
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Figure 1 - Mean serum calcium concentrations (mg/dl) (a), bone alkaline phosphatase (BAP) (U/l) 
(b) and intact parathyroid hormone (iPTH) (pg/ml) (c) for group 1 (1st intervention 
(weeks 0-11): standard drink and 2nd intervention (weeks 14-25): test drink) and group 2 
(1st intervention (weeks 0-11): test drink and 2nd intervention (weeks 14-25): standard 
drink); * significant difference among the times of sampling according to the weeks of 
study (Profile test); ** significant difference between groups (Tukey test). 
 
 
 
The results of ANOVA for repeated measures for 
the crossover study are presented in Table 2. It 
was observed that the carryover effect did not 
present significant statistical difference for any of 
the biochemical parameters (Table 2), showing 
that a 3-week washout period was enough to 
eliminate the residual effects of the administered 
formulation and it did not persist when crossing 
the experimental periods. It was also possible to 
observe that fructans did not show cumulative 
effect on the organism. In this kind of experiment, 
it is important to separate residual effects from 
treatment effects. Sampling times according to the 
weeks of study showed significant differences for 
all the evaluated biochemical parameters (Table 
2), which could be observed in Figure 1. When the 
treatment-exclusive effect was evaluated, there 
was a significant difference between the treatment 
with the standard drink and the treatment with the 
test drinks for BAP (Table 2). When the 
interaction between the treatment and intervention 
period was studied, again BAP presented a 
significant difference between both the treatments 
per intervention period (1st and 2nd periods) 
(Table 2). 
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Table 2 - Statistical data of the effects of standard and test drinks on biochemical parameters in the crossover study. 
Biochemical parameter/Effect Calcium* BAP* iPTH* 
Carryover effect NS NS NS 
Sampling time effect P<0.001 a P<0.001 b P<0.001 c 
Treatment effect NS P<0.001 b NS 
Interaction treatment x intervention 
period 
NS P=0.006 b NS 
Intervention sequence/group effect P<0.001 a P<0.001 b P<0.001 c 
*BAP, bone alkaline phoshatase; iPTH, intact parathyroid hormone; NS, not significant (P<0.05). 
Asignificant effect of the sampling times according to the weeks of study and intervention sequence: significant difference between 
sampling times in the 2nd period for both groups (22nd week different from other weeks and significant difference between periods of 
intervention (1st-11th≠14th-25th week) in group 1. 
bsignificant effect of sampling times according to the weeks of study, interaction between treatment versus intervention period and 
intervention sequence; significant difference between treatments (standard≠ test drink); significant difference between the times in the 
2nd period for both groups (22nd week different from other times in group 1 and 18th week different from other times in group 2);  
significant difference between periods (1st-11th≠14th-25th week) in group 1. 
csignificant effect of sampling times according to the weeks of study and intervention sequence: significant different between times in the 
1st and 2nd intervention periods for group 1 (4th and 22nd week different from other times); and significant difference between periods (1st-
11th≠14th-25th week) in group 1. 
* variable transformed in logarithm (log10) due to absence of normal distribution; ANOVA results. Group 1 (1st period: 1st-11th - 
standard drink and 2nd period: 14th-25th week - test drink. Group 2 (1st period - test drink and 2nd period - standard drink). 
 
 
In the study of intervention sequence effect per 
group, a significant difference was observed in 
serum calcium, BAP and iPTH (Table 2). Serum 
calcium showed a significant increase in the 2nd 
period compared to the 1st period in group 1 (1st 
period – standard drink and 2nd period – test 
drink). BAP showed a significant increase in the 
2nd period (supplementation with test drink) 
compared to the 1st period in group 1. iPTH 
showed a significant reduction in the 2nd period 
compared to the 1st period in group 1, when the 
treatment sequence was considered (1st period – 
standard drink and 2nd  period – test drink). The 
following significant results for the variables were 
found for group 1: serum calcium and bone 
alkaline phosphatase increased in the 2nd period 
(supplementation with test drink); intact 
parathyroid hormone decreased in the 2nd period 
(supplementation with test drink). 
Once the studied population could present 
hyperparathyroidism due to inadequate calcium 
intake, the correlation between the serum calcium 
and intact parathyroid hormone was analyzed. 
Therefore, the area under incremental curve 
(AUIC), which corresponded to a profile of the 
parameters measured along the times, was 
evaluated. The Spearman correlation was used, 
once the data did not present a normal distribution. 
A significant negative correlation (r= -0.609;  
 
P=0.009) was observed between the measured 
evolutions (AUIC) of serum calcium and iPTH in 
group 2, in the second experimental period, that is, 
the increase of serum calcium related to the higher 
fall of iPTH. 
 
 
DISCUSSION 
 
In the present study, children were enrolled in 
public schools and presented very low mean 
calcium intakes. Such low calcium intakes in 
students living in Sao Paulo were observed before 
by Lerner et al. (2000), who observed a mean 
calcium intake for both the males and females of 
about 50% of the recommended level. Participants 
in economically better areas presented higher daily 
intakes (630 + 324 mg) compared to the 
participants of lower incomes (524 + 298 mg). The 
latter was close to the mean of the present study 
group (500 mg/d). Although the evidence of the 
positive impact of adequate calcium intakes on 
bone metabolism was clear, inadequate calcium 
intakes commonly occurred (Ilich and Kerstetter, 
2000).  
The present study used a crossover design, where 
each patient received the two kinds of treatment, 
and the order of supplementation was the only 
variation. In this kind of experimental design, each  
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volunteer is his/her own control, which avoids 
confusions in relation to the analysis of results, 
mainly at this age when there is intense growth.   
Results showed that the supplementation of 200 
mg/d of calcium, prior to supplementation with 
oligofructose-enriched inulin, improved the 
plasma calcium level, possibly increased the bone 
formation (as indicated by the increase in BAP, 
which demonstrated higher bone metabolic 
activity) and reduced iPTH. These effects were not 
observed with calcium supplementation alone. The 
effect of the oligofructose-enriched inulin could be 
ascribed to the higher proportion of absorption of 
the supplemental calcium, as observed in other 
studies (Griffin et al., 2002; 2003; Abrams et al., 
2004; 2005). Biochemical markers of bone 
metabolism were measured in the present study 
because of the shorter time of intervention 
necessary to evaluate them. Children in their 
growth phase (9 to 12 years) have a bone 
remodeling period that takes a few weeks 
(Heaney, 2001b), which allows to estimate the 
effect of dietary intervention strategies on markers 
of bone metabolism in a limited time period. 
Indeed, the efficiency of measuring bone 
metabolism biomarkers has been demonstrated 
(van Coeverden et al., 2002). Studies in diverse 
animal models have shown the beneficial effect of 
inulin and oligofructose in the colonic epithelium, 
stimulating proliferation in the crypts, increasing 
the concentration of polyamines, changing the 
profile of mucins and modulating endocrine as 
well as immune functions (Roberfroid, 2005; 
Budiño et al., 2005), and on calcium absorption 
and bone mass (Roberfroid, 2002; Scholz-Ahrens 
et al., 2002; Cashman, 2003; Kruger et al., 2003; 
Lobo et al., 2006). This was also observed in 
adolescents (Griffin et al., 2002), showing a 
significant increase in calcium absorption with 
oligofructose-enriched inulin supplementation (8 
g/d of Synergy1). In a subsequent study, the 
authors observed that those individuals with lower 
baseline calcium absorption had a higher response 
to supplementation with oligofructose-enriched 
inulin (8 g/d of Synergy1) (Griffin et al., 2003). 
However, in these last two studies, mean calcium 
intake was close to the adequate one, presenting 
1510 + 255 mg/d in the first study, and 1140 + 650 
mg/d in the second study. 
Another study (Abrams et al., 2005) observed that 
a long-term supplementation with oligofructose-
enriched inulin (8 g/d of Synergy1) increased bone 
mineral density and content significantly in 
adolescents, indicating that the higher percentage 
of absorbed calcium was accreted by the bone. 
This was observed through the comparison with 
the control group, which received placebo during 
the period, demonstrating that the result was not 
due to the growth of the studied group. According 
to the authors, the magnitude of the benefit 
depends on genetic alterations in calcium 
absorption due to an interaction between the Fok 1 
gene, presenting three polymorphic types (FF, Ff 
and ff), and the response of each of them to the 
oligofructose-enriched inulin.  
Furthermore, there is a supposition that some 
genotypes may be more benefited by the daily 
intake of fructans, and also because of individual 
variations in fructan intakes. People with low 
fructan intakes may present a reduced calcium 
absorption, but a good response to BeneoTM 
Synergy1, and people with high intake of fructans 
may have better calcium absorption, but a poorer 
response to BeneoTM Synergy1 (Griffin et al., 
2003). The high fructan intakes in this Brazilian 
population (7.09 + 3.7 g/d) might, however, have 
minimized the effect of inulin-type 
supplementation.  
In a recent study, Abrams et al. (2004) observed an 
increase in calcium absorption in the girls with 
low calcium intakes (63.4%), compared to the girls 
with adequate calcium intakes (44.9%). That is 
positive, but absorption generally does not exceed 
60 to 70% even in adolescents (Food and Nutrition 
Board, 1997). The authors observed an absorption 
adaptation at a very low intake (386 mg/d). 
However, when calcium balance was evaluated, it 
remained lower in the group with reduced calcium 
intakes. This suggested that, during the present 
experiment, even though the participants did not 
have their calcium absorption evaluated and also 
presented reduced calcium intakes and possibly a 
high mineral absorption, there was a partial 
improvement in calcium absorption, specially 
when consumed together with fructan, possibly to 
soften calcium state, which was not adequate, and 
interfered in the bone metabolism, demonstrated 
by the increase in serum calcium and BAP and the 
decrease in iPTH. This pointed the necessity of 
future studies with populations that have low 
calcium intakes in order to evaluate calcium 
absorption and bone mass. 
One of the factors that determines thefracture 
resistance at adult age is the quantity of bone mass 
that was gained during the growth (Borges and 
Brandão, 2006), which demonstrates the 
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importance of this kind of study in children and 
adolescents.  
Frazão and Naveira (2006), in a review of studies 
about the prevalence of osteoporosis in Brazil, 
observed a small number of studies and the 
necessity of implementing projects mainly in 
developed regions of the country aiming to use 
prevalence data in public health projects. A great 
part of the population, especially the females in 
Brazil, was at risk of reduced mass gain and low 
bone mineralization during adolescence caused by 
deficient calcium intake. Adequate prevention 
strategies, therefore, needed to be urgently 
implemented. Among these, there is the 
consumption of foods that are sources of calcium, 
foods fortified with calcium or foods with 
increased bioavailability. The results of this study 
indicated the potential of supplementing the daily 
diet with oligofructose-enriched inulin to improve 
the bone metabolism in adolescent girls. 
To conclude, the present study indicated that the 
supplementation of a calcium-enriched 
(200mg/200ml) milk-based drink with 
oligofructose-enriched inulin (8 g/d of BeneoTM 
Synergy1) to the diet of prepubertal girls (with low 
habitual calcium intake) was well tolerated and 
beneficially altered markers of bone metabolism. 
This was shown by a higher bone formation 
(increase in BAP) and serum calcium levels and a 
decrease in iPTH. The effect of oligofructose-
enriched inulin appeared after an 11-week calcium 
supplementation period and it indicated a possible 
dependence on food calcium concentration for the 
subjects with low calcium intakes. The beneficial 
effect of oligofructose-enriched inulin on calcium 
metabolism could help adolescents to reach their 
peak of bone mass acquisition.  
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RESUMO  
 
No presente ensaio clínico, o efeito de oligofrutose 
enriquecida com inulina foi estudado no 
metabolismo ósseo de meninas de 9 a 12 anos com 
baixa ingestão habitual de cálcio, matriculadas em 
escolas públicas. Duas formulações foram 
suplementadas ou não (bebida padrão) com 
oligofrutose enriquecida com inulina (bebida 
teste). Sessenta meninas pré-púberes foram 
aleatorizadas em estudo duplo cego crossover e 
divididas em três grupos e receberam uma porção 
diária da bebida padrão (grupo 1) ou teste (grupo 
2) durante 11 semanas, seguidos por um período 
de intervalo de três semanas. O grupo controle não 
recebeu nenhuma suplementação. As avaliações 
bioquímicas de cálcio sérico, paratormônio intacto 
– PTHi e fosfatase alcalina fração óssea – FAO 
foram executadas ao início e após 4, 8 e 11 
semanas de cada período de intervenção. No grupo 
1, um aumento significante no cálcio sérico e FAO 
e uma redução no PTHi foram observadas após o 
consumo da bebida teste. 
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